Catalyst Wire Dossier Catalyst Wire Dossier

BUPIVACAINE HCL

BUPIVACAINE HYDROCHLORIDE · Xellia Pharmaceuticals USA LLC
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BUPIVACAINE HCL, covering 2011-10-18 to 2025-02-28. Get the full timeline:

Most recent: FDA Approved: BUPIVACAINE HCL — Supplemental Application (Xellia Pharmaceuticals USA LLC)

See pricing